Is the data reviewed by a Board-Certified Pathologist?

Our "Pharma DNA" means we believe in building a data package that is scientifically sound and fit for its purpose. We do not rely solely on automated outputs; every study includes expert human oversight to ensure what we're seeing is true biology, not artifact. Our standard review is performed by expert scientists with more than 30 years of histopathology experience, guaranteeing decision-grade data.

We recognize that certain key studies, particularly those involving preclinical safety or complex pathology, benefit from formal certification. For these projects, we provide Board-Certified Pathologist review as an integrated service, ensuring your most critical data has the highest level of verification needed to support major investment or regulatory decisions.

This flexible, on-demand capability ensures you receive the precise level of pathologist-verified IHC scoring and expert oversight your project requires without adding unnecessary overhead to every study.